China NMPA Approves Bio-Thera Solutions’ BAT1806, A Biosimilar to Actemra® (Tocilizumab)
World’s First Approved Biosimilar to Actemra® GUANGZHOU, China--(BUSINESS WIRE)--#Actemra--Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage biopharmaceutical company, announced that the...




















